U.S. Court of Appeals for the Federal Circuit, 2024

United Therapeutics Corporation v. Liquidia Technologies, Inc.

United Therapeutics Corporation v. Liquidia Technologies, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided October 10, 2024
United Therapeutics Corporation v. Liquidia Technologies, Inc.

Opinion

Case: 24-1658 Document: 53 Page: 1 Filed: 10/10/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

UNITED THERAPEUTICS CORPORATION,

Plaintiff-Appellant v.

LIQUIDIA TECHNOLOGIES, INC.,

Defendant-Appellee ______________________

2024-1658 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00755-RGA, Judge Richard G. Andrews. ______________________

ON MOTION ______________________

Before PROST, HUGHES, and CUNNINGHAM, Circuit Judges. PER CURIAM.

ORDER

United Therapeutics Corporation moves to dismiss the above-captioned appeal pursuant to Fed. R. App. P. 42(b) with each side to bear its own costs.

Upon consideration thereof, Case: 24-1658 Document: 53 Page: 2 Filed: 10/10/2024

2 UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC.

IT IS ORDERED THAT:

The motion is granted.

FOR THE COURT

October 10, 2024

Date

ISSUED AS A MANDATE: October 10, 2024

Case-law data current through September 30, 2026. Source: CourtListener bulk data.